Wow_老虎社区_美港股上老虎

GerardBungee
2021-12-23

Wow

Canopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’

Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a

Canopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":691707989,"tweetId":"691707989","gmtCreate":1640237633301,"gmtModify":1640237633362,"author":{"id":3577068348393147,"idStr":"3577068348393147","authorId":3577068348393147,"authorIdStr":"3577068348393147","name":"GerardBungee","avatar":"https://static.tigerbbs.com/ed18bbfb3b78ae0c31b89056409c9938","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Wow</p></body></html>","htmlText":"<html><head></head><body><p>Wow</p></body></html>","text":"Wow","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/691707989","repostId":1103220602,"repostType":4,"repost":{"id":"1103220602","kind":"news","pubTimestamp":1640237254,"share":"https://www.laohu8.com/m/news/1103220602?lang=&edition=full","pubTime":"2021-12-23 13:27","market":"us","language":"en","title":"Canopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’","url":"https://stock-news.laohu8.com/highlight/detail?id=1103220602","media":"Barrons","summary":"Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a","content":"<p>Canopy Growth&nbsp;was downgraded at BofA Securities with the analysts noting “execution challenges and a tough Canadian&nbsp;operating environment.”</p>\n<p>Analyst Lisa Lewandowski wrote in a note Wednesday that she sees “long-term potential for the legal cannabis industry driven by U.S. federal legalization and changing attitudes toward cannabis consumption,” but was downgrading the stock of Canopy Growth (ticker: CGC) to Underperform from Neutral.</p>\n<p>U.S.-listed shares of the Canadian cannabis company fell 3% to $9.37. The stock has declined 62% in 2021.</p>\n<p>Lewandowski said Canopy Growth’s relationship with&nbsp;Constellation Brands&nbsp;(STZ) was a plus, but the company “has shown&nbsp;mixed progress on key performance metrics, is&nbsp;confronted&nbsp;with&nbsp;a rapidly&nbsp;evolving&nbsp;Canadian market with new entrants taking&nbsp;market&nbsp;share&nbsp;and changing consumer tastes,&nbsp;lackluster industry growth&nbsp;even with&nbsp;new stores&nbsp;opening and&nbsp;limited visibility for&nbsp;profitability.”</p>\n<p>Constellation Brands owns a 36% stake in Canopy Growth, according to FactSet.</p>\n<p>Recent management changes at the company and the planned sale of C3, a German pharmaceutical company, were efforts at Canopy Growth that “will take time to show results,” the analyst said.</p>\n<p>BofA reduced its price target on U.S. shares to $7.94&nbsp;from&nbsp;$15.15.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanopy Growth Stock Is Downgraded Again, This Time on ‘Execution Challenges’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 13:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/canopy-growth-cgc-stock-downgrade-cannabis-51640192812?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a tough Canadian operating environment.”\nAnalyst Lisa Lewandowski wrote in a note Wednesday that she ...</p>\n\n<a href=\"https://www.barrons.com/articles/canopy-growth-cgc-stock-downgrade-cannabis-51640192812?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/canopy-growth-cgc-stock-downgrade-cannabis-51640192812?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103220602","content_text":"Canopy Growth was downgraded at BofA Securities with the analysts noting “execution challenges and a tough Canadian operating environment.”\nAnalyst Lisa Lewandowski wrote in a note Wednesday that she sees “long-term potential for the legal cannabis industry driven by U.S. federal legalization and changing attitudes toward cannabis consumption,” but was downgrading the stock of Canopy Growth (ticker: CGC) to Underperform from Neutral.\nU.S.-listed shares of the Canadian cannabis company fell 3% to $9.37. The stock has declined 62% in 2021.\nLewandowski said Canopy Growth’s relationship with Constellation Brands (STZ) was a plus, but the company “has shown mixed progress on key performance metrics, is confronted with a rapidly evolving Canadian market with new entrants taking market share and changing consumer tastes, lackluster industry growth even with new stores opening and limited visibility for profitability.”\nConstellation Brands owns a 36% stake in Canopy Growth, according to FactSet.\nRecent management changes at the company and the planned sale of C3, a German pharmaceutical company, were efforts at Canopy Growth that “will take time to show results,” the analyst said.\nBofA reduced its price target on U.S. shares to $7.94 from $15.15.","news_type":1},"isVote":1,"tweetType":1,"viewCount":697,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}